A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for theTreatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects

Project: Research project

Description

A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects
StatusActive
Effective start/end date2/6/192/29/24

Funding

  • ANSUN BIOPHARMA, INC.

Fingerprint

Paramyxoviridae Infections
Respiratory Tract Infections
Placebos
Safety
Therapeutics
DAS181